U.S. flag

An official website of the United States government, Department of Justice.

Lynchburg Adult Drug Treatment Court

Award Information

Award #
15PBJA-21-GG-04177-DGCT
Location
Congressional District
Status
Open
Funding First Awarded
2022
Total funding (to date)
$550,000

Description of original award (Fiscal Year 2022, $550,000)

Horizon Behavioral Health proposes to expand the Lynchburg Adult Drug Court (ADC), currently at capacity with 10 participants.  Without funding, ADC is unable to meet the current arrestee volume.  The proposed category of funding is category 3, Adult Drug Court.  The primary activities of this project are to expand current treatment and recovery supports for individuals eligible for ADC.  ADC eligible participants must live in the Lynchburg City, Virginia limits and have a drug-related criminal record which does not include a violent offense.  The overarching project goals include ADC participant reduction in substance use, reduced recidivism, and stable housing and employment.  With expanded services and supports, ADC will be able to enroll an additional 15 unduplicated participants per year for the four-year duration of the project.  Funding will expand capacity to serve an additional 60 participants during the course of the project.  The minimum length of program participation is expected to be 12 months.  The maximum length of program participation is expected to be 24 months, and the average length of program participation is expected to be 18 months.   Primary activities will include project staff training and delivery of evidence-based treatment to participants, including Moral Reconation Therapy (MRT) and Community Reinforcement Approach (CRA).  Both models demonstrate efficacy with the population of focus and have a broad research base with participants from diverse backgrounds (i.e., different ages, cultures, genders, and races).  Funding will also augment recovery supports through peer recovery and recovery housing.  The target population for ADC will have access to Medication Assisted Treatment (MAT) through Horizon's Office-Based Opioid Therapy (OBOT) program as well as community providers, including Lynchburg Treatment Center.  Every participant in ADC will have access to MAT if there is an FDA-approved medication for their substance use disorder.  We are not leveraging other federal funding sources to support the drug court nor have we previously received a drug court grant from OJP.  The ten key components of NADCP drug court standards will be met as evidenced in the program narrative pages 3, 4, 5, 8,12, and 13.   Partnerships are outlined in the MOU with Horizon and the key drug court team members (i.e., judge, probation officer, Commonwealth's attorney, public defender, drug court coordinator, law enforcement, and treatment provider).  Data will be collected at baseline/entry into treatment, six months post baseline, and at discharge from treatment.  Data collection will include both quantitative (e.g., GAIN Q-3) and qualitative measures (e.g., focus groups, surveys).  Data will be used to guide programming, evaluate outcomes, and develop project sustainability after funding ends.

Date Created: December 17, 2021